ESOMAR-certified consulting firm Future Market Insights recently published a report on the global ophthalmic eyes drops market for the forecast period 2021-2031. As per the study, the market is expected to expand at over 5% CAGR through 2021 & beyond. Surging cases of post-operative eye infections and ocular surgical cases such as glaucoma, cataract, and many more are furthering the sales of dilation eye drops.
Ocular surgical conditions such as diabetic retinopathy, age-related macular degeneration, and glaucoma have increased the demand for post-operative ocular anti-infective therapies. Also, rising cases of bacterial and viral conjunctivitis and the emergence of various pathogens have increased the risk of eye infection, thereby fostering the sales of ophthalmic eye drops.
According to the World Health Organization, around 60% of patients in the U.S. are prescribed with antibiotic eye drops and approximately 10 million people across the globe undergo cataract surgery each year. Furthermore, around 7.7 million people in the U.S. were affected with diabetic retinopathy. Hence, demand for dilation eye drops is increasing with the mounting cases of eye surgery each year. Based on the aforementioned factors, the global ophthalmic eye drops market is expected to witness staggering growth throughout the forecast period.
“Rising cases of cataract and diabetic retinopathy especially among the growing geriatric population and demand for specific eye drops are pushing the manufacturers to develop customized products in ophthalmic eye drops market,” says the FMI analyst
For more Insights into the Market, Request a Sample of this Report https://www.futuremarketinsights.com/reports/sample/rep-gb-13140
- Demand for dilation eye drop is growing across the globe and is likely to expand at a CAGR of over 5.3% through 2031
- By drug formulation, with the preservative segment is accounted to hold over 89.2% global market share
- Increasing cases of dry eyes across the globe are making it a dominant indication segment
- The institutional sales segment is anticipated to account for over 60.4% of market share
- While the U.S. is expected to hold the largest share of North America with 92.1% of market share, Canada is expected to be the fastest-growing market.
- Rising cases of eye infection across the U.K. and France will spur the sales
- Germany is expected to lead Europe’s ophthalmic eye drop market through 2021 & beyond
- India is expected to be the most lucrative market for the South Asia region, while China and Japan are leading East Asia’s market
FMI has profiled some of the prominent market players providing ophthalmic eye drops that include Novartis AG, Bausch & Lomb, Akorn Inc., Biomedica, Advacare Pharma, C2 PHARMA, Kraeber GmbH, Iskon Remedies, HANSHIN Group, Berry Global Inc., Nolato AB, Bormioli Pharma, WG Pro-Manufacturing Inc., Adelphi Healthcare Packaging, Aptar Group Inc., Amcor PLC, and Gerresheimer AG among others. Prominent manufacturers are deploying a slew of expansion strategies, ranging from product innovation to strategic collaboration & partnerships to maintain the lead in the industry,
In February 2021, Bausch & Lomb, the global leading eye health company, and Nicox, an ophthalmic company announced that VYZULTA (latanoprostene bunod ophthalmic solution), 0.024%, received regulatory approval from the Ministry of Food and Drug Safety in South Korea. The product is indicated for the reduction of intraocular pressure in patients with open-angle glaucoma in the U.S. and other states.
Also, Ocuphire Pharma Inc., a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of several eye disorders announced the results of ORION-1 Phase 2 clinical trial evaluating the safety & efficacy of Nyxol in glaucoma and presbyopia.
Furthermore, in July 2020, Alcon, the global leader in eye care dedicated to helping people see, announced the U.S. Food and Drug Administration approval for PAZEO, an olopatadine hydrochloride ophthalmic eye care solution for patients in the U.S.
Get Customization on this Report for Specific Country https://www.futuremarketinsights.com/customization-available/rep-gb-13140
More Insights on the Global Ophthalmic eye drops Market
Future Market Insights, in its new offering, provides an unbiased analysis of the ophthalmic eye drops market, presenting historical demand data (2016-2020) and forecast statistics for the period from 2021-2031. The study divulges compelling insights on the ophthalmic eye drops market with a detailed segmentation on the basis of drug class (anesthetic drops, dilation drops, glaucoma drops, steroid drops, antibiotic drops, and others (antihistamine, and lubricants tear drops)), indication (dry eye, eye allergy, glaucoma, eye infection, retinal disorders (macular degeneration, diabetic retinopathy, and others), uveitis, and others), drug formulation (with preservative and preservative-free), container type (single-dose container and multiple-dose container), distribution channel (institutional sales, hospitals, community clinics, ophthalmic clinics, public health agencies, veterinary hospitals & clinics, retail sales, and drug stores), across major regions (North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East & Africa)
Key Questions Covered in the Report
- How will the market for ophthalmic eye drops expand through 2031?
- Which top manufacturing companies are leading the global ophthalmic eye drops market?
- What are the key drivers and trends that will stimulate the ophthalmic eye drops sales?
- What are the challenges that will affect the sales of ophthalmic eye drops market?
- Which region will remain the most lucrative throughout the forecast period?
- What is the impact of Covid-19 on ophthalmic eye drops market?
For any Queries Linked with the Report, Ask an Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-13140
Explore FMI’s Extensive Coverage on Healthcare Domain
Eye Infections Treatment Market: The eye infections treatment market study by Future Market Insights (FMI) provides deeper insights on the new trends while incorporating the impact of ongoing trends, and growth & restraining factors during the forecast period of 2021 to 2031. Market dynamics have been presented on the basis of prominent drivers, trends, and opportunities prevailing across key geographies for the aforementioned decade.
Ophthalmic Viscosurgical Devices Market: ESOMAR-certified market analysis and consulting company Future Market Insights (FMI) provides insights driving ophthalmic viscosurgical devices market demand in the latest report. Additionally, to find the effect of COVID-19 on the ophthalmic viscosurgical devices market in general, the study monitor global ophthalmic viscosurgical devices sales in 20+ high-growth markets and addresses their end-user in particular.
Eye Socket Implants Market: In its latest study, ESOMAR-certified market research and consulting firm Future Market Insights (FMI) offers in-depth insights on key factors that influence the demand for eye socket implants. The report covers global demand for Fish powder in more than 20 high potential markets, in addition to an in-depth analysis of the impact of COVID-19 on the global eye socket implants market.
About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai and has delivery centers in the UK, U.S., and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.